(Q40911311)

24 September 2017

title

Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer (English)

1 reference

24 September 2017

Ricol D

1

1 reference

24 September 2017

Cappellen D

2

1 reference

24 September 2017

El Marjou A

3

1 reference

24 September 2017

Gil-Diez-de-Medina S

4

1 reference

24 September 2017

Girault JM

5

1 reference

24 September 2017

Yoshida T

6

1 reference

24 September 2017

Ferry G

7

1 reference

24 September 2017

Tucker G

8

1 reference

24 September 2017

Poupon MF

9

1 reference

24 September 2017

Chopin D

10

1 reference

24 September 2017

Thiery JP

11

1 reference

24 September 2017

Radvanyi F

12

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

24 September 2017

1 reference

24 September 2017

volume

18

1 reference

24 September 2017

issue

51

1 reference

24 September 2017

page(s)

7234-7243

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203186

24 September 2017

exact match

0 references

cites work

Growth factors and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Growth factors in development, transformation, and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Skeletal disorders associated with fibroblast growth factor receptor mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Fibroblast growth factor receptor 3 is a negative regulator of bone growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Promiscuity of fibroblast growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

E-cadherin germline mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

bFGF is the putative natural growth factor for human melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

A soluble form of K-sam/FGFR2 protein in the culture medium of human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

21 January 2018

Bladder cancer, 1996.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Pancreatic beta cells cultured from individual preneoplastic foci in a multistage tumorigenesis pathway: a potentially general technique for isolating physiologically representative cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Purification and characterization of a newly identified growth factor specific for epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Use of a HpaII-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Peptide growth factors are multifunctional

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

7 January 2021

Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

7 January 2021

Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

7 January 2021

Tumour-suppressor genes: evolving definitions in the genomic age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

7 January 2021

Tumor suppressor genes: does FHIT fit?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

7 January 2021

Assignment by in situ hybridization of a fibroblast growth factor receptor gene to human chromosome band 10q26

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

7 January 2021

The heparan sulfate-fibroblast growth factor family: diversity of structure and function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

7 January 2021

The int-2 gene product acts as an epithelial growth factor in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

7 January 2021

Keratinocyte growth factor as a cytokine that mediates mesenchymal-epithelial interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

7 January 2021

Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203186

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203186

1 reference

Dimensions Publication ID

24 September 2017

1029112218

0 references

1 reference